OpenAlex
PricingAboutJobs
Log inGet started
Work

Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression

HTML

Year: 2024
Type: article
Source: Inflammopharmacology
DOI: 10.1007/s10787-024-01565-1
Authors: Parviz Soufivand, Ghazal Hosseini Torshizi, Seyed Askar Roghani, Mohammad Dastbaz, Ramin Lotfi, Bijan Soleymani, Fatemeh Heydarpour, Zahra Abdan, Hosna Allahyari
Institutions: Kermanshah University of Medical Sciences, Islamic Azad University, Mashhad, Kurdistan University of Medical Sciences, High Institute for Education and Research in Transfusion Medicine
Language: English

Topic: Rheumatoid Arthritis Research and Therapies
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: rheumatoid arthritis, disease-modifying antirheumatic drugs, Foxp3, regulatory T cells, semaphorins, neuropilin-1, PlexinD1, interleukin-6, IL-10, gene expression, disease activity, inflammation, newly diagnosed patients, peripheral blood
SDG: Good health and well-being

Open Access status: closed

Funder: Deputy for Research and Technology, Kermanshah University of Medical Sciences
Award: G8971269394
OpenAlex ID: W4402217543
FWCI: 1.438
Cites: 36
Cited by: 6
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms